Interleukin-6 (IL-6) - A molecule with both beneficial and destructive potentials

Progress in Neurobiology

Volumn 52, Issue 5, 1997, Pages 379-390

  Gadient, Reto A ^a   Otten, Uwe H ^b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b Department of Physiology Vesalianum ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADRENAL MEDULLA; ALZHEIMER DISEASE; ASTROCYTE; CELL SURVIVAL; FEVER; HUMAN; MICROGLIA; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE INJURY; NEUROIMMUNOLOGY; NEUROPROTECTION; NOCICEPTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; REVIEW;

ALZHEIMER DISEASE; ANIMALS; HUMANS; INTERLEUKIN-6; NERVOUS SYSTEM PHYSIOLOGY; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

EID: 0030964023     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(97)00021-X     Document Type: Review

References (134)

1. Adams, E. F., Rafferty, B., Mower, J., Ward, H., Petresen, B. and Fahlbusch, R. (1994) Human acoustic neuromas secrete interleukin-6 in cell culture: possible autocrine regulation of cell proliferation. Neurosurgery 35, 434-438.
2. Akaneya, Y., Takahashi, M. and Hatanaka, H. (1995) Interleukin-1β enhances survival and interleukin-6 protects against MPP-neurotoxicity in cultures of fetal rat dopaminergic neurons. Expl Neurol. 136, 44-52.
3. Banks, W. A., Kastin, A. J. and Gutierrez, E. G. (1994) Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 179, 53-56.
4. Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Volk, B. and Berger, M. (1991) Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114.
5. Benveniste, E. N., Sparacio, S. M., Norris, J. G., Grenett, H. E. and Fuller, G. M. (1990) Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30, 201-212.
6. Blum-Degen, D., Müller, T., Kühn, W., Gerlach, M., Przuntek, H. and Riederer, P. (1995) Interleukin-1ß and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202, 17-20.
7. Bolin, L. M., Verity, A. N., Silver, J. E., Shooter, E. M. and Abrams, J. S. (1995) Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 64, 850-858.
8. Bourde, O., Kiefer, R., Toyka, K. V. and Hartung, H. P. (1996) Quantification of interleukin-6 messenger RNA in Wallerian degeneration by reverse transcription-polymerase chain reaction. J. Neuroimmunol. 69, 135-140.
9. Brakenhoff, J. P. L., Dehon, F. D., Fontaine, V., Tenboekel, E., Schooltink, H., Rose-John, S., Heinrich, P. C., Content, J. and Aarden, L. A. (1994) Development of a human interleukin-6 receptor antagonist. J. Biol. Chem. 269, 86-93.
10. Breitner, J. C. S., Gau, B. A., Welsh, K. A., Plassman, B. L., McDonald, W. M., Helmas, M. J. and Antony, J. C. (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology 44, 227-232.
11. Breitner, J. C. S., Welsh, K. A., Helms, M. J., Gaskell, P. C., Gau, B. A., Roses, A. D., Pericak-Vance, M. A. and Saunders, A. M. (1995) Delayed onset of Alzheimer's disease with non-steroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16, 520-523.
12. Brett, F. M., Mizisin, A. P., Powell, H. C. and Campbell, I. L. (1995) Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Expl Neurol. 54, 766-775.
13. Brugg, B., Dubreuil, Y. L., Huber, G., Wollman, E. E., Delhayebouchaud, N. and Mariani, J. (1995) Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. natn. Acad. Sci. U.S.A. 92, 3032-3035.
14. Cadman, E. D., Naugles, D. D. and Lee, C. (1994a) cAMP is not involved in interleukin-1-induced interleukin-6 release from human astrocytoma cells. Neurosci. Lett. 178, 251-254.
15. Cadman, E. D., Witte, D. G. and Lee, C. (1994b) Regulation of the release of interleukin-6 from human astrocytoma cells. J. Neurochem. 63, 980-987.
16. Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B. A. and Mucke, L. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. natn. Acad. Sci. U.S.A. 90, 10061-10065.
17. Chai, Z., Gatti, S., Tonatti, C., Poli, V. and Bartfai, T. (1996) Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide of IL-lß: A study on IL-6-deficient mice. J. Expl Med. 183, 311-316.
18. Chiang, C., Stalder, A., Samimi, A. and Campbell, I. L. (1994) Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev. Neurosci. 16, 212-221.
19. Cornfield, L. J. and Sils, M. A. (1991) High affinity interleukin-6 binding sites in bovine hypothalamus. Eur. J. Pharmacol. 202, 113-115.
20. Darnell, J. E. J., Kerr, I. M. and Stark, G. R. (1994) JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
21. De Leo, J. A., Colburn, R. W., Nichols, M. and Malkotra, A. (1996) Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16, 695-700.
22. Dehon, F. D., Ehlers, M., Rose-John, S., Ebeling, S. B., Bos, H. K., Aarden, L. A. and Brakenhoff, J. P. J. (1994) Development of an interleukin (IL)-6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. J. Expl Med. 180, 2395-2400.
23. Del Bo, R., Angeretti, N., Lucca, E., De Simoni, M. G. and Forloni, G. (1995) Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures. Neurosci. Lett. 188, 70-74.
24. Ehlers, M., Dehon, F. D., Bos, H. K., Horsten, U., Kurapkat, G., Vandeleur, H. S., Grotzinger, J., Wollmer, A., Brakenhoff, J. P. J. and Rose-John, S. (1995) Combining 2 mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells. J. Biol. Chem. 270, 8158-8163.
25. Ershler, W. B., Sun, W. H. and Binkley, N. (1994) The role of interleukin-6 in certain age-related diseases. Drugs and Aging 5, 358-365.
26. Fann, M.-J. and Patterson, P. H. (1994) Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc. natn. Acad. Sci. U.S.A. 91, 43-47.
27. Fattori, E., Lazzaro, D., Musiani, P., Modesti, A., Alonzi, T. and Ciliberto, G. (1995) IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur. J. Neurosci. 7, 2441-2449.
28. Frei, K., Leist, T. P., Maeger, A., Gallo, P., Leppert, D., Zinkernagel, R. M. and Fontana, A. (1988) Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. J. Expl Med 168, 449-453.
29. Frei, K., Malipiero, U. V., Leist, T. P., Zinkernagel, R. M., Schwab, M. and Fontana, A. (1989) On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19, 689-694.
30. Gadient, R. A., Lachmund, A., Unsicker, K. and Otten, U. (1995) Expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat adrenal medulla. Neurosci. Lett. 194, 17-20.
31. Gadient, R. A. and Otten, U. (1993) Differential expression of interleukin-6/interleukin-6 receptor mRNAs in rat hypothalamus. Neurosci. Lett. 153, 13-16.
32. Gadient, R. A. and Otten, U. (1994a) Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res. 637, 10-14.
33. Gadient, R. A. and Otten, U. (1994b) Identification of interleukin-6 (IL-6) expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci. Lett. 182, 243-246.
34. Gadient, R. A. and Otten, U. (1996) Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia. Brain Res. 724, 41-46.
35. Gallo, P., Laverda, A. M., De Rossi, A., Pagni, S., Del Mistro, A., Cago, P., Picinno, M. G., Plebani, A., Tavolato, B. and Bianchi, C. L. (1991) Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Paediatr. Scand. 80, 659-666.
36. Ganter, U., Strauss, S., Jonas, U., Weidemann, A., Beyreuther, K., Volk, B., Berger, M. and Bauer, J. (1991) Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer β-amyloid precursor protein. FEBS Lett. 282, 127-131.
37. Gijbels, K., Brocke, S., Abrams, J. S. and Steinman, L. (1995) Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation. Molec. Med. 1, 795-805.
38. Gijbels, K., van Damme, J., Proost, P., Put, W., Carton, H. and Billiau, A. (1990) Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 20, 233-235.
39. Gitter, B. D., Regoli, D., Howbert, J. J., Glasebrook, A. L. and Waters, D. C. (1994) Interleukin-6 secretion from human astrocytoma cells induced by substance P. J. Neuroimmunol. 51, 101-108.
40. Gottschall, P. E., Tatsuno, I. and Akimura, A. (1994) Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res. 637, 197-203.
41. Grau, G. E., Frei, K., Piguet, P.-F., Fontana, A., Heremans, H., Billiau, A., Vassalli, P. and Lambert, P.-H. (1990) Interleukin 6 production in experimental cerebral malaria: Modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J. Expl Med. 172, 1505-1508.
42. Grimaldi, M., Pozzoli, G., Navarra, P., Preziosi, P. and Schettini, G. (1994) Vasoactive intestinal peptide and forskolin stimulate interleukin 6 production by rat cortical astrocytes in culture via a cyclic AMP-dependent, prostaglandin-independent mechanism. J. Neurochem. 63, 344-350.
43. Hama, T., Kushima, Y., Miyamoto, M., Kubota, M., Takei, N. and Hatanaka, H. (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40, 445-452.
44. Hama, T., Miyamoto, M., Tsukui, H., Nishio, C. and Hatanaka, H. (1989) Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci. Lett. 104, 340-344.
45. Hariri, R. J., Chang, V. A., Barie, P. S., Wang, R. S., Sharif, S. F. and Ghajar, J. B. G. (1994) Traumatic injury induces interleukin-6 production by human astrocytes. Brain Res. 636, 139-142.
46. Heaney, M. L. and Golde, D. W. (1996) Soluble cytokine receptors. Blood 87, 847-857.
47. Hirano, T., Matsuda, T. and Nakajima, K. (1994) Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Stem Cells 12, 262-277.
48. Hirohata, H., Kiyama, H., Kishimoto, T. and Taga, T. (1996) Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J. Expl Med. 183, 2627-2634.
49. Hirohata, S. and Miyamoto, T. (1990) Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthr. Rheum. 33, 644-649.
50. Holliday, J., Parsons, K., Curry, J., Lee, S. Y. and Gruol, D. L. (1995) Cerebellar granule neurons develop elevated calcium responses when treated with interleukin-6 in culture. Brain Res. 673, 141-148.
51. Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., Osugi, Y., Tokunaga, T. and Kishimoto, T. (1992) Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148, 2175-2180.
52. Houssiau, F. A., Bukasa, K., Sindic, C. J., Van Damme, J. and Van Snick, J. (1988) Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in the cerebrospinal fluid of patients with acute infection of the central nervous system. Clin. Expl Immunol. 71, 320-323.
53. Hüll, M., Strauss, S., Berger, M., Volk, B. and Bauer, J. (1996) The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav. Brain Res. 78, 37-41.
54. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K. and Silvennoinen, O. (1995) Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369-398.
55. Ikeda, K., Iwasaki, Y., Shiojima, T. and Kinoshita, M. (1996a) Neuroprotective effects of various cytokines on developing spinal motoneurons following axotomy. J. Neurol. Sci. 135, 109-113.
56. Ikeda, K., Kinoshita, M., Tagaya, N., Shiojima, T., Taga, T., Yasukawa, K., Suzuki, H. and Okano, A. (1996b) Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease. Brain Res. 726, 91-97.
57. Imamura, K., Suzumura, A., Hayashi, F. and Marunouchi, T. (1993) Cytokine production by peripheral-blood monocytes macrophages in multiple sclerosis patients. Acta Neurol. Scand. 87, 281-285.
58. Kiefer, R., Lindholm, D. and Kreutzberg, G. W. (1993) Interleukin-6 and transforming growth factor-β1 mRNAs are induced in rat facial nucleus following motoneuron axotomy. Eur. J. Neurosci. 5, 775-781.
59. Kishimoto, T., Akira, S., Narazaki, M. and Taga, T. (1995) Interleukin-6 family of cytokines and gp130. Blood 86, 1243-1254.
60. Kishimoto, T., Taga, T. and Akira, S. (1994) Cytokine signal transduction. Cell 76, 253-262.
61. Kossmann, T., Hans, V., Imhof, H. G., Trentz, O. and Morganti-Kossmann, M. C. (1996) Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production by astrocytes. Brain Res. 713, 143-152.
62. Kossmann, T., Hans, V. H. J. and Imhof, H. G. (1995) Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 4, 311-317.
63. Kushima, Y. and Hatanaka, H. (1992) Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci. Lett. 143, 110-114.
64. Labourdette, G. and Sensenbrenner, M. (1995) Growth factors and their receptors in the central nervous system. In: Neuroglia, pp. 441-459. Eds H. H. Kettenmann and B. R. Ransom. Oxford University Press: Oxford.
65. Laurenzi, M. A., Sidén, A., Persson, M. A. A., Norkrans, G., Hagberg, L. and Chiodi, F. (1990) Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. Clin. Immunol. Immunopathol. 57, 233-241.
66. Lee, S. C., Liu, W., Dickson, D. W., Brosnan, C. F. and Berman, J. W. (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1β. J. Immunol. 150, 2659-2667.
67. LeMay, L. G., Otterness, I. G., Vander, A. and Kluger, M. J. (1990) In vivo evidence that the rise in plasma IL-6 following injection of a fever-inducing dose of LPS is mediated by IL-1β. Cytokine 2, 199-204.
68. Luheshi, G., Miller, A. J., Brouwer, S., Dascombe, M. J., Rothwell, N. J. and Hopkins, S. J. (1996) Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am. J. Physiol. Endocrinol. Metabol. 33, E91-E95.
69. Mackiewicz, A., Wiznerowicz, M., Roeb, E., Karczewska, A., Nowak, J., Heinrich, P. C. and Rose-John, S. (1995) Soluble interleukin 6 receptor is biologically active in vivo. Cytokine 7, 142-149.
70. Maeda, Y., Matsumoto, M., Hori, O., Kuwabara, K., Ogawa, S., Yan, S. D., Ohtsuki, T., Kinoshita, T., Kamada, T. and Stern, D.M. (1994) Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J. Expl Med. 180, 2297-2308.
71. Maimone, D., Annunziata, P., Salvadori, C., Malandrini, A. and Guazzi, G. C. (1993a) IL-6 detection in multiple sclerosis brain. Neurology 43, A162-A162.
72. Maimone, D., Annunziata, P., Simone, I. L., Livrea, P. and Guazzi, G. C. (1993b) Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J. Neuroimmunol. 47, 55-62.
73. Maimone, D., Cioni, C., Rosa, S., Macchia, G., Aloisi, F. and Annuziata, P. (1993c) Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1β and TNFα. J. Neuroimmunol. 47, 73-82.
74. Maimone, D., Reder, A. T. and Gregory, S. (1993) T-cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis. J. Cell. Immunol. 146, 96-106.
75. März, P., Gadient, R. A. and Otten, U. (1996) Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor α (TNF-α). Brain Res. 706, 71-79.
76. März, P., Herget, T., Lang, E., Otten, U. and Rose-John, S. (1997) Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur. J. Neurosci. (submitted for publication).
77. Matsuda, S., Wen, T., Morita, F., Otsuka, H., Igase, K., Yoshimura, H. and Sakanaka, M. (1996) Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci. Lett. 204, 109-112.
78. McGeer, P. L. and McGeer, E. G. (1995) The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195-218.
79. Merrill, J. E. (1992) Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev. Neurosci. 14, 1-10.
80. Minami, M., Kuraishi, Y. and Satoh, M. (1991) Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176, 593-598.
81. Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M. and Nagatsu, T. (1994) Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180, 147-150.
82. Murphy, P. G., Grondin, J., Altares, M. and Richardson. P. M. (1995) Induction of interleukin-6 in axotomized sensory neurons. J. Neurosci. 15, 5130-5138.
83. Nakafuku, M., Satoh, T. and Kaziro, Y. (1992) Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active ras-GTP complex in rat pheochromocytoma PC12 cells. J. Biol. Chem. 267, 19448-19454.
84. Navikas, V., Matusevicius, D., Soderstrom, M., Fredrikson, S., Kivisakk, P., Ljungdahl, A., Hojeberg, B. and Link, H. (1996) Increased interleukin-6 messenger RNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis, J. Neuroimmunol. 64, 63-69.
85. Nordlind, K., Chin, L. B., Ahmed, A. A., Brakenhoff, J., Theodorsson, E. and Lidén, S. (1996) Immunohistochemical localization of interleukin-6-like immunoreactivity to peripheral nerve-like structures in normal and inflamed human skin. Arch. Dermatol. Res. 288, 431-435.
86. Norris, J. G. and Benveniste, E. N. (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J. Neuroimmunol. 45, 137-146.
87. Norris, J. G., Tang, L., Sparacio, S. M. and Benveniste, E. N. (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1β and tumor necrosis factor-α. J. Immunol. 152, 841-850.
88. Oka, T., Oka, K., Hosoi, M. and Hori, T. (1995) Intracere-broventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res. 692, 123-128.
89. Palma, C., Goso, C. and Manzini, S. (1994) Different susceptibility to neurokinin 1 receptor antagonists of substance P and septide-induced interleukin-6 release from U373 MG human astrocytoma cell line. Neurosci. Lett. 171, 221-224.
90. Perella, O., Carrieri, P. B., Guarnaccia, D. and Soscia, M. (1992) Cerebrospinal fluid cytokines in AIDS dementia complex. J. Neurol. 239, 387-388.
91. Qiu, Z., Parsons, K. L. and Gruol, D. L. (1995) Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons. J. Neurosci. 15, 6688-6699.
92. Reichert, F., Levitzky, R. and Rotshenker, S. (1996) Interleukin 6 in intact and injured mouse peripheral nerves. Eur. J. Neurosci. 8, 530-535.
93. Richards, C. D. and Gauldie, J. (1994) The acute-phase protein response. In: Textbook of Immunopharmacohgy, pp. 269-276. Eds M. M. Dale, J. C. Foreman and T. P. Fan. Blackwell Scientific Publications: Oxford.
94. Righi, M., Mori, L., De Libero, G., Sironi, M., Biondi, A., Mantovani, A., Denis Donini, S. and Ricciardi-Castagnoli, P. (1989) Monokine production by microglial cell clones. Eur. J. Immunol. 19, 1443-1448.
95. Ringheim, G. E., Burgher, K. L. and Heroux, J. A. (1995) Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J. Neuroimmunol. 63, 113-123.
96. Rodriguez, M., Pavelko, K. D., McKinney, C. W. and Leibowitz, J. L. (1994) Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153, 3811-3821.
97. Rogers, J., Webster, S., Lue, L., Brachova, L., Civin, W. H., Emmerling, M., Shivers, B., Walker, D. and McGeer, P. (1996) Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17, 681-686.
98. Rose-John, S. and Heinrich, P. C. (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281-290.
99. Rothwell, N. J., Busbridge, N. J., Lefeuvre, R. A. and Hardwick, A. J. (1991) IL-6 is a centrally acting endogenous pyrogen in the rat. Can. J. Physiol. Pharmacol. 69, 1465-1469.
100. Rubio, N. and Sierra, A. (1993) Interleukin-6 production by brain tissue and cultured astrocytes infected with Theiler's murine encephalomyelitis virus. Glia 9, 41-47.
101. Sarder, M., Abe, K., Saito, H. and Nishiyama, N. (1996) Comparative effect of IL-2 and IL-6 on morphology of cultured hippocampal neurons from fetal rat brain. Brain Res. 715, 9-16.
102. Satoh, T., Nakamura, S., Taga, T., Matsuda, T., Hirano, T., Kishimoto, T. and Kaziro, Y. (1988) Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol. Cell. Biol. 8, 3546-3549.
103. Savino, R., Lahm, A., Salvati, A. L., Ciapponi, L., Sporeno, E., Altamura, S., Paonessa, G., Toniatti, C. and Ciliberto, G. (1994) Generation of interleukin-6 receptor antagonists by molecular modeling guided mutagenesis of residues important for gp130 activation. EMBO J. 13, 1357-1367.
104. Sawada, M., Suzumura, A. and Marunouchi, M. (1992) TNFα induces IL-6 production by astrocytes but not by microglia. Brain Res. 583, 296-299.
105. Schöbitz, B., De Kloet, E. R. and Holsboer, F. (1994a) Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain. Progr. Neurobiol. 44, 397-432.
106. Schöbitz, B., de Kloet, E. R., Sutano, W. and Holsboer, F. (1993) Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5, 1426-1435.
107. Schöbitz, B., Holsboer, F., Sutano, W., Gross, G., Schönbaum, E. and de Kloet, E. R. (1994b) Corticosterone modulates interleukin-evoked fever in the rat. Neuroendocrinology 59, 387-395.
108. Schöbitz, B., Pezeshki, G., Pohl, T., Hemmann, U., Heinrich, P. C., Holsboer, F. and Reul, J. M. H. M. (1995) Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J. 9, 659-664.
109. Schöbitz, B., Voorhuis, D. A. M. and de Kloet, E. R. (1992) Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci. Lett. 136, 189-192.
110. Sébire, G., Emilie, D., Wallon, C., Héry, C., Devergne, O., Delfraissy, J.-F., Galanaud, P. and Tardieu, M. (1993) In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J. Immunol. 150, 1517-1523.
111. Selmaj, K. W., Farooq, M., Norton, W. T., Raine, C. S. and Brosnan, C. F. (1990) Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 144, 129-135.
112. Shalaby, M. R., Waage, A., Aarden, L. and Espevik, T. (1989) Endotoxin, tumor necrosis factor α and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 53, 488-498.
113. Spangelo, B. L., Judd, A. M., MacLeod, R. M., Goodman, D. W. and Isakson, P. C. (1990) Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology 127, 1779-1785.
114. Steffensen, S. C., Campbell, I. L. and Henriksen, S. J. (1994) Site-specific hippocampal pathophysiology due to cerebral overexpression of interleukin-6 in transgenic mice. Brain Res. 652, 149-153.
115. Sterneck, E., Kaplan, D. R. and Johnson, P. F. (1996) Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. J. Neurochem. 67, 1365-1374.
116. Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, M. and Volk, B. (1992) Detection of interleukin-6 and α2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
117. Suzuki, H., Yasukawa, K., Saito, T., Goitsuka, R., Hasegawa, A., Ohsugi, Y., Taga, T. and Kishimoto, T. (1992) Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur. J. Immunol. 22, 1989-1993.
118. Suzuki, H., Yasukawa, K., Saito, T., Narazaki, M., Hasegawa, A., Taga, T. and Kishimoto, T. (1993) Serum soluble interleukin-6 receptor in MRL/1pr mice is elevated with age and mediates the interleukin-6 signal. Eur. J. Immunol. 23, 1078-1082.
119. Toulmond, S., Vige, X., Fage, D. and Benavides, J. (1992) Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. 144, 49-52.
120. Tyor, W. R., Glass, J. D., Griffin, J. W., Becker, P. S., McArthur, J. C., Bezman, L. and Griffin, D. E. (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31, 349-360.
121. Van Gool, D., Strosper, B., van Leuven, F., Triau, E. and Dom, R. (1993) α2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease. Neurobiol. Aging 14, 233-237.
122. Van Meir, E. G. (1995) Cytokines and tumors of the central nervous system. Glia 15, 264-288.
123. Waage, A., Halstensen, A., Shalbaby, R., Brandtzaeg, P., Kierulf, P. and Espevik, T. (1989) Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis. J. Expl Med. 170, 1859-1867.
124. Wells, M. R., Racis, S. P. Jr and Vaidya, U. (1992) Changes in plasma cytokines associated with peripheral nerve injury. J. Neuroimmunol. 39, 261-268.
125. Wesselingh, S. L., Gough, N. M., Finlay-Jones, J. J. and McDonald, P. J. (1990) Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymph. Cyt. Res. 9, 177-185.
126. Wood, J. A., Wood, P. L., Ryan, R., Graff-Radford, N. R., Pilapil, C., Robitaille, Y. and Quirion, R. (1993) Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein. Brain Res. 629, 245-252.
127. Woodroofe, M. N. and Cuzner, M. L. (1993) Cytokine messenger RNA expression in inflammatory multiple sclerosis lesions-detection by nonradioactive in-situ hybridization. Cytokine 5, 583-588.
128. Woodroofe, M. N., Sarna, G. S., Wadhwa, M., Hayes, G. M., Loughlin, A. J., Tinker, A. and Cuzner, M. L. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33, 227-236.
129. Wu, Y. Y. and Bradshaw, R. A. (1996a) Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. J. Biol. Chem. 271, 13023-13032.
130. Wu, Y. Y. and Bradshaw, R. A. (1996b) Synergistic induction of neurite outgrowth by nerve growth factor or epidermal growth factor and interleukin-6 in PC12 cells. J. Biol. Chem. 271, 13033-13039.
131. Yamada, M. and Hatanaka, H. (1994) Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643, 173-180.
132. Yan, H. O., Alcaros Banos, M., Herregodts, P., Hooghe, R. and Hooghe-Peters, E. L. (1992) Expression of interleukin (IL)-1β, IL-6 and their respective receptors in the normal rat brain and after injury. Eur. J. Immunol. 22, 2963-2971.
133. Yasukawa, K., Hirano, T., Watanabe, Y., Muratani, K., Matsuda, T., Nakai, S. and Kishimoto, T. (1987) Structure and expression of human B-cell stimulatory factor-II (BSF-2/IL-6). EMBO J. 6, 2939-2945.
134. Yoshioka, M., Shapshak, P., Srivastava, A. K., Stewart, R. V., Nelson, S. J., Bradley, W. G., Berger, J. R., Rhodes, R. H., Sun, N. C. J. and Nakamura, S. (1994) Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 44, 1120-1130.